# US 2016/0353774 A1 · Nutritional compositions comprising spore-forming probiotics

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2016/0353774 A1
- Document ID: US20160353774A1
- Status: Published application
- Kind: A1
- Application number: 14/727,978
- Filed: 2015-06-02
- Published: 2016-12-08
- Earliest claimed: 2015-06-02
- Applicants: Mead Johnson Nutrition Company
- Inventors: Juan M. Gonzalez
- Web page: https://patentgrep.com/patent/US20160353774A1

## CPC

- A23L 33/17: Amino acids, peptides or proteins
- A23L 33/10: using additives (addition of substantially indigestible substances A23L33/21)
- A23L 33/12: Fatty acids or derivatives thereof
- A23L 33/135: Bacteria or derivatives thereof, e.g. probiotics
- A23L 33/21: Addition of substantially indigestible substances, e.g. dietary fibres
- A23L 33/26: Polyol polyesters, e.g. sucrose polyesters; Synthetic sugar polymers, e.g. polydextrose
- A23L 33/40: {Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula}
- A23L: FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF (preservation thereof A23B)

## Abstract

Disclosed are nutritional compositions for pediatric subjects, such as children's nutritional products and infant formulas, which include a protein or protein equivalent source, a fat, a carbohydrate, and a spore-forming probiotic.

## Claims

### Claim 1

A nutritional composition for a pediatric subject, comprising:
a fat;
a carbohydrate;
a protein or protein equivalent source source; and
a spore-forming probiotic.

### Claim 2 (depends on 1)

The nutritional composition of claim 1, wherein the spore-forming probiotic comprises Bacillus coagulans.

### Claim 3 (depends on 2)

The nutritional composition of claim 2, wherein the nutritional composition comprises at least 1×106 cfu Bacillus coagulans per 100 kcal nutritional composition.

### Claim 4 (depends on 3)

The nutritional composition of claim 3, wherein the nutritional composition comprises Bacillus coagulans in the range of about 1×106 cfu to about 1×109 cfu per 100 kcal nutritional composition.

### Claim 5 (depends on 1)

The nutritional composition of claim 1, further comprising a prebiotic.

### Claim 6 (depends on 5)

The nutritional composition of claim 5, wherein the prebiotic comprises polydextrose and galacto-oligosaccharide.

### Claim 7 (depends on 1)

The nutritional composition of claim 1, further comprising at least one long chain polyunsaturated fatty acid.

### Claim 8 (depends on 7)

The nutritional composition of claim 7, wherein the long chain polyunsaturated fatty acid is selected from the group consisting of docosahexaenoic acid, arachidonic acid, or combinations thereof.

### Claim 9 (depends on 8)

The nutritional composition of claim 8, wherein the ratio of arachidonic acid:docosahexaenoic acid by weight is from about 1:3 to about 9:1.

### Claim 10 (depends on 1)

The nutritional composition of claim 1, wherein the nutritional composition is an infant formula.

### Claim 11

A method for enhancing immune function of a pediatric subject by administering to the pediatric subject a nutritional composition, comprising:
a fat;
a carbohydrate;
a protein or protein equivalent source;
a prebiotic; and
a spore-forming probiotic,
wherein the administration of the nutritional composition enhances the immune function of the pediatric subject.

### Claim 12 (depends on 11)

The method of claim 11, wherein the spore-forming probiotic comprises Bacillus coagulans.

### Claim 13 (depends on 12)

The method of claim 12, wherein the nutritional composition comprises at least 1×106 cfu Bacillus coagulans per 100 kcal nutritional composition.

### Claim 14 (depends on 13)

The method of claim 13, wherein the nutritional composition comprises Bacillus coagulans in the range of about 1×106 cfu to about 1×10 dcfu per 100 kcal nutritional composition.

### Claim 15 (depends on 11)

The method of claim 11, further comprising a prebiotic, wherein the prebiotic comprises polydextrose and galacto-oligosaccharide.

### Claim 16 (depends on 11)

The method of claim 11, further comprising at least one long chain polyunsaturated fatty acid selected from the group consisting of docosahexaenoic acid, arachidonic acid, or combinations thereof.

### Claim 17 (depends on 11)

The method of claim 11, wherein the nutritional composition is an infant formula.
